Clinically Studied Vemma Formula
.
State-of-the-Art Methods and Facilities Yield Premium Nutrition
Vemma’s state-of-the-art manufacturing facility is a comprehensive and highly efficient site where quality nutrition takes center stage. Chief Scientific Officer Yibing Wang, M.D., Ph.D., oversees facility operations and ingredient sourcing, while over 200 tests and an extensive 30-step quality control process ensure Vemma’s high standards of quality are met.
.
The Vemma Clinical Trials were conducted by one of the industry’s most widely recognized experts in Independent Clinical Testing, Brunswick Laboratories in Norton, MA. The intention of these studies was to evaluate the efficacy and overall bioavailability of a mangosteen product containing multivitamins, essential minerals and antioxidants (Vemma) on immune function and well-being in adults. This was done by subjecting the product to the gold standard of clinical research — the independent, double-blind, placebo-controlled study that follows a specific set of procedures to ensure that the results are dependable and free from bias. The studies confirmed Vemma showed significant improvements in immune markers, superior antioxidant absorption and a lowering of C-reactive protein (CRP), which points to its beneficial effects on overall health and wellness.*
Yibing Wang, M.D.
Yibing Wang, M.D.
“It is rare in the wellness industry that a company would do clinical studies, simply because they’re not required. But to have two clinical studies done on the Vemma formula and have them published in peer-reviewed journals is absolutely huge.”
– Yibing Wang, M.D., Ph.D.
Vemma Chief Scientific Officer
Vemma Chief Scientific Officer
Effect of a Mangosteen Dietary Supplement on Human Immune Function: A Randomized, Double-Blind, Placebo-Controlled Trial
Journal of Medicinal Food, August 2009 Issue
The purpose of the first independent, randomized, double-blind placebo study evaluated how Vemma enhanced immune function and well-being in humans.* Participants were randomly divided into two groups and received 2 ounces of Vemma or placebo each morning for 30 days. After the 30-day evaluation, the study showed favorable results in immune markers and a lowering of C-reactive protein (CRP) while taking Vemma.*
.
.
.
…
..
.
.
.
.
.
.
.
Bioavailability and Antioxidant Effects of a Xanthone-Rich Mangosteen (Garcinia mangostana) Product in Humans
Journal of Agricultural and Food Chemistry, October 14, 2009 Issue
This study was designed to determine the overall bioavailability (body readiness) and antioxidant effect of the Vemma formula in the body. This trial took place over a 24-hour period. Participants were separated into two groups, placebo and the Vemma formula. Before the products were consumed, each participant’s blood was measured. Then, participants either received a single dose of the Vemma formula or placebo. Blood samples were collected and evaluated. The data concluded that Vemma is highly bioavailable.*
No comments:
Post a Comment